Complete androgen insensitivity syndrome and anti-Müllerian hormone levels before and after laparoscopic gonadectomy

[1]  L. Wünsch,et al.  Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis , 2012, BJU international.

[2]  G. Conway,et al.  Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidence , 2012, Clinical endocrinology.

[3]  R. Nimri,et al.  Androgen insensitivity syndrome: risk of malignancy and timing of surgery in a paediatric and adolescent population. , 2011, African journal of paediatric surgery : AJPS.

[4]  K. Main,et al.  Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. , 2010, The Journal of clinical endocrinology and metabolism.

[5]  Jacques Young,et al.  Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. , 2009, The Journal of clinical endocrinology and metabolism.

[6]  L. Looijenga,et al.  Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. , 2006, Endocrine reviews.

[7]  M. Forest,et al.  Anti-müllerian hormone in children with androgen insensitivity. , 1994, The Journal of clinical endocrinology and metabolism.

[8]  G. Müller.  Anti-Müllerian hormone , 1978, Nature.

[9]  H. Jones,et al.  The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. , 1976, American journal of obstetrics and gynecology.